Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Cardiology/Vascular Diseases
Clinical Trials: Congestive Heart Failure
A listing of clinical trials currently looking for volunteers to enroll in Congestive Heart Failure studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Huntsville : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Mobile : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Arizona
Mesa :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Mesa : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Phoenix :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Scottsdale :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Scottsdale : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Tucson :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Arkansas
Little Rock : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
California
Anaheim :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Culver City : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Fairfield :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Fountain Valley :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Glendale : Glendale Memorial Hospital and Health Center
Does Lung Impedance Correlate With Changes in BNP in Stable and Acutely Decompensated Heart Failure Patients?
View More »
Glendale :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Hawthorn :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Inglewood :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
La Jolla : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Los Angeles :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Los Angeles : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Modesto : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
National City :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Northridge :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Orange :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Rancho Mirage :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Redondo Beach : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Sacramento : UC Davis Medical Center
Ventricular Rate Regularization for Improved Quality of Life in Patients With CHF and AF
San Francisco : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Santa Barbara :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Santa Rosa : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Torrance :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Ventura :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Walnut Creek : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Watsonville :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Westlake Village : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Colorado
Aurora :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Boulder :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Denver : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Connecticut
Bridgeport : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Delaware
Newark, : Christiana Care Health Services
Utilizing Blood Volume Measurements in the Treatment of Heart Failure Patients
Florida
Miami : Pharmax Research Clinic, Inc.
Myocardial Infarction in the last 3 months?
Tampa : Tampa Clinical Research
Are you undergoing treatment for Congestive Heart Failure?
View More »
Davenport :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Edgewater :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Jacksonville Beach : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Jupiter : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Land O' Lakes :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Melbourne :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Melbourne : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Miami : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Naples :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Safety Harbor : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Sarasota : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Georgia
Atlanta : Grady Memorial Hospital
BNP Therapy Observation Unit Outcomes STudy (BOOST)
Atlanta : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Atlanta : Investigative Site
Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure
Covington : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Illinois
Elk Grove Village : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Melrose Park : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Oakbrook Terrace : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Peoria : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Rockford : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Springfield : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Urbana :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Indiana
Fort Wayne :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Indianapolis : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Valparaiso :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Iowa
Iowa City : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Kansas
Wichita : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Kentucky
Louisville : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Owensboro :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Louisiana
Alexandria : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Covington :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Covington : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Lafayette :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Slidell : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Maine
Bangor :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Maryland
Baltimore : Spectrum Clinical Research, Inc.
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction
View More »
Baltimore :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Cumberland :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Lanham :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Massachusetts
Ayer : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Boston : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Burlington :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Haverhill : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
North Dartmouth : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Worcester :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Worcester : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Michigan
Ann Arbor :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Detroit : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Lansing :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Lapeer :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Saginaw :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
View More »
Wyoming :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Ypsilanti :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Minnesota
Duluth : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Minneapolis : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Missouri
Crystal City :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
St. Louis :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Montana
Kalispell : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Nebraska
Lincoln : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Nevada
Las Vegas :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
New Jersey
Glen Ridge :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Newark : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Voorhees : Southern New Jersey Cardiac Specialists
Does Lung Impedance Correlate With Changes in BNP in Stable and Acutely Decompensated Heart Failure Patients?
New York
Buffalo : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Cortlandt Manor : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Kingston : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
New York :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
New York : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
New York : NYU College of Medicine
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
New York : Columbia University Medical Center
T-wave Alternans and Intrathoracic Impedance Measurements
Rochester :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Rochester : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Roslyn : St. Francis Hospital
Does Lung Impedance Correlate With Changes in BNP in Stable and Acutely Decompensated Heart Failure Patients?
Syracuse : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Williamsville : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
North Carolina
Asheville : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Burlington : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Chapel Hill : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Charlotte : Carolinas Healthcare System/The Sanger Clinic
Does Lung Impedance Correlate With Changes in BNP in Stable and Acutely Decompensated Heart Failure Patients?
Charlotte : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Durham : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Gastonia :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Gastronia : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Winston-Salem :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Winston-Salem : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Ohio
Canton : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Cincinnati : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Cleveland : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Columbus : The Ohio State University
Effects of Mitral Valve Repair With the Geoform Ring on Cardiomyopathy
Columbus :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
View More »
Garfield Heights : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Mayfield Heights : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Middletown :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Sandusky : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Steubenville :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Toledo :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Oklahoma
Oklahoma City : Oklahoma Foundation for Cardiovascular Research
Seeking Oklahomans with Congestive Heart Failure who are unable to walk across a room without experiencing shortness of breath and fatigue.
View More »
Oklahoma City :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Oklahoma City : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Tulsa : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Oregon
Portland : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Salem :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Pennsylvania
Chinchilla :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Lancaster :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Lancaster : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Philadelphia :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Philadelphia : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Pittsburgh : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Pottstown :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Yardley :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Rhode Island
Pawtucket : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
South Carolina
Anderson : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Charleston : Medical University of South Carolina
Correlation of Intrathoracic Impedance Measures With Blood Plasma Volume in Congestive Heart Failure
Charleston : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Columbia :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Greenville :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
View More »
Orangeburg : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Spartanburg :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Tennessee
Chattanooga :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Germantown : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Jackson : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Memphis : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Nashville : Mid State Cardiology Associates
Does Lung Impedance Correlate With Changes in BNP in Stable and Acutely Decompensated Heart Failure Patients?
View More »
Tullahoma : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Texas
Amarillo :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Brownsville :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Corpus Christi :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Dallas :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Dallas : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Houston : The Methodist Hospital
Feasibility Study of BMAC Enhanced CABG
Houston : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Kingwood :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
McKinney :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Nacogdoches :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Utah
Salt Lake City : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Virginia
Midlothian : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Richmond : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Roanoke : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Washington
Kirkland : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Seattle : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Spokane :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Tacoma : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Yakima :
Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar
Wisconsin
Argentina
Adrogue : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Adrogue : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Bahia Blanca : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Bahia Blanca : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Buenos Aires : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Buenos Aires : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Capital Federal : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Capital Federal : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Cipolletti : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Cipolletti : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Ciudad Autónoma de Buenos Aires : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Ciudad Autónoma de Buenos Aires : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Cordoba : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Cordoba : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Corrientes : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
La Plata : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
La Plata : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Mar del Plata : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Mar del Plata : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Quilmes : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Quilmes : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Rosario : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
San Justo : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Santa Fe : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Australia
Bedford Park : Flinders Medical Centre Updated
IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction
Geelong : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Heidelberg : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Melbourne, Victoria : The Northern Hospital Updated
IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction
Melbourne, Victoria : Alfred Hospital Updated
IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction
View More »
Prahran : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Austria
Innsbruck : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Linz : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Salzburg : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Wien : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Belgium
Aalst : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Antwerpen : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Bonheiden : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Brussel : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Brussels : UCL Bruxelles
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
View More »
Genk : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Hasselt : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Huy : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Leuven : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Roeselare : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Turnhout : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Brazil
Campinas : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Campinas : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Curitiba : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Curitiba : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Fortaleza : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Fortaleza : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Goiania : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Goiania : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Porto Alegre : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Porto Alegre : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Recife : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Riberão Preto : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Riberão Preto : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Rio De Janeiro : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Rio de Janeiro : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
São Paulo : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Sao Paulo : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Sao Paulo : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
São Paulo : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Bulgaria
Haskovo : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Pleven : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Plovdiv : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Rouse : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Sofia : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Veliko Tarnovo : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Canada
Halifax : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Hamilton : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Mississauga : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Montreal : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Ottawa : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Scarborough : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
St. John's : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Toronto : St Michael's Hospital
Improvement of Patients With Chronic Heart Failure Using NT-proBNP
Toronto : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Winnipeg : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Chile
Osorno : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
San Miguel : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Santiago : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Czech Republic
Benesov : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Brno : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Havirov : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Karlovy Vary : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Litomysl : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
View More »
Pardubice : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Pardubice : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Prague : Investigative Site
Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure
Praha 10 : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Praha 2 : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Praha 4 : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Praha 6 : Ustredni vojenska nemocnice
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Pribram 8 : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Denmark
Frederiksberg : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Glostrup : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Hellerup : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Herlev : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
København Ø : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
København S : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
København Ø : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
København S : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Odense : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Roskilde : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Svendborg : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Estonia
Pärnu : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Parnu : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Pärnu : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Tallinn : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Tallinn : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Tartu : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
France
Grenoble Cedex 9 : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Lille : CHRU de Lille - Hôpital Cardiologique
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
Lille Cedex : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Montfermeil : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Montpellier cedex 05 : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Paris : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Pessac Cedex : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Poitiers : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Pontoise Cedex : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Saint Herblain : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Toulouse Cedex 09 : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Vandoeuvre les Nancy : Centre d'Investigation Clinique Pierre Drouin, CHU de Nancy
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
Germany
Aachen : Universitätsklinikum Aachen
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
Aachen : Praxis Dr. Frieske
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
Alsdorf : Praxis Dr. Nossek
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Arnsberg : Gemeinschaftspraxis Weiß/ Dr. Heesing
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
Bad Krozingen : Herzzentrum Bad Krozingen
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
View More »
Bad Oeynhausen : Herz- u. Diabeteszentrum NRW/Ruhr-Univ. Bochum
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Bad Oeynhausen : Hdz Nrw
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
Bergisch Gladbach : Kardiopraxis Rheinberg
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
Berlin : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Berlin : Jüdisches Krankenhaus Berlin
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
Berlin : Praxis Westend
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
Berlin : Unfallkrankenhaus Berlin
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
Berlin : Charité Campus Mitte
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
Berlin : Gemeinschaftspraxis Groß-Ziethener Chaussee
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
Berlin : POLIKUM Friedenau
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
Bernau : Evangelisch-Freikirchliches Krankenhaus und Herzzentrum Brandenburg in Bernau
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
Bernau : Herzzentrum Brandenburg
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
Bielefeld : Praxis für Lunge,Herz und Schlaf
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
Bochum : Kardiologie Gemeinschaftspraxis Dr. Tenholt
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
Bochum : Augusta Krankenanstalten Bochum
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
Bochum : Kardiologische Praxis Dr. Staubach
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
Bonn : Kardiologische Praxis Marschner
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
Dresden : GWT-TUD GmbH
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Frankfurt : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Fulda : Gemeinschaftspraxis Unterm Heilig Kreuz
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Georgsmarienhütte : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Georgsmarienhütte : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Göttingen : Universitätsmedizin Göttingen
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
Hamburg : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Ingelheim : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Kamp-Lintfort : Praxis Dr. Heisters
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Leipzig : Universitätsklinikum Leipzig
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
Leipzig : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Mainz : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Marburg : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Nürnberg : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Neuwied : Zentrum für Klinische Forschung Neuwied (ZKSN)
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Nürnberg : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Oberhausen : Praxis Dr. Etter
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Rostock : Universitätsklinikum Rostock
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
Saarlouis : Praxis Dr. Alawi
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Schwedt : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Senden : Praxis Fröhlich
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Stuttgart : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Warburg : Praxis Dr. Böhmer
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Guatemala
Guatemala City : Unidad de Cirugía Cardiovascular de Guatemala
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Guatemala City : Cardio Care
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Guatemala City : Clínica Dr. Fernando Wyss
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Guatemala City : Clinica Dr. Rodriguez
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Hong Kong
Hong Kong : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Sha Tin : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
India
Ahmedabad : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Ahmedabad : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Bangalore : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Bikaner : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Chennai : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Coimbatore : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Gurgaon : Medanta The Medicity
BMAC Enhanced Coronary Artery Bypass Grafting (CABG)
Gurgaon : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Gurgaon : Medanta the Medicity
Retrograde Delivery of BMAC (Bone Marrow Aspirate Concentrate) for Congestive Heart Failure
Hyderabad : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Hyderabad : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Jaipur : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Ludhiana : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Ludhiana : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Mumbai : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Mumbai : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Mumbai : Investigative Site
Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure
Nagpur : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Nagpur : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Nashik : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Nashik : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
New Delhi : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
New Delhi : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Pune : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Pune : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Trivandrum : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Visakhapatnam : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Israel
Ashkelon : Barzilai Medical Center Updated
IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction
Askelon : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Beer Sheva : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Givatayim : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Hadera : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Haifa : B'nai Zion Medical Center Updated
IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction
Haifa : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Holon : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Jerusalem : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Kfar Saba : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Rehovot : Kaplan Medical Center Updated
IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction
Safed : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Tel Aviv : Tel Aviv Medical Center
Extracorporeal Shockwave Myocardial Revascularization (ESMR) Therapy For The Treatment of Chronic Heart Failure
Tel viv : Theravitae Co.
ACPs Combined With CABG in Patients With CHF
Italy
Bergamo : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Cesenatico (FC) : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Cortona : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Eboli : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Ferrara : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Firenze : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Forlì : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Mercato San Severino : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Milano : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Novara : A.Osp-Univ.Maggiore dellaCarità
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Palermo : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Passirana : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Pavia : Fondaz.Salvatore Maugeri-IRCCS-Ist.Scient.Pavia (Centro Med)
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Roma : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Udine : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Latvia
Daugavpils : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Daugavpils : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Preili : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Riga : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Lithuania
Alytus : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Kaunas : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Kaunas : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Klaipeda : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Siauliai : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Vilnius : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Vilnius : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Mexico
Distrito Federal : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Distrito Federal : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Guadajalara : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Guadalajara : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Jalapa : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Merida : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Merida : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Mexico City : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Mexico City : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Monterrey : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Monterrey : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
San Luis Potosi : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
San Luis Potosi : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Netherlands
Almelo : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Arnhem : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Breda : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Delft : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Den Haag : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Deventer : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Groningen : Martini Hospital
Peritoneal Dialysis in Congestive Heart Failure
Groningen : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Haarlem : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Harderwijk : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Heerlen : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Hoorn : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Rotterdam : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Norway
Ã…lesund : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Ålesund : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Arendal : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Oslo : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Skien : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Stavanger : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Poland
Bialystok : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Gdansk : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Gdynia : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Krakow : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Lublin : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Stalowa Wola : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Warsawa : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Warszawa : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Wroclaw : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Wroclaw : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Zabrze : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Zielona Gora : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Portugal
Coimbra : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Faro : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Lisbon : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Puerto Rico
San Juan : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Romania
Arad : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Bacau : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Brasov : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Brasov : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Bucharest : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
View More »
Bucuresti : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Craiova : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Oradea : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Targu Mures : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Russian Federation
Kaliningrad : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Kazan : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Krasnodar : Kuban State Medical University
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Moscow : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
N.Novgorod : N.Novgorod City Hospital#13
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
View More »
Penza : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Saint Petersburg : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Saint-Petersburg : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Samara : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Sankt-Petersburg : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Saratov : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
St Petersburg : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
St. Petersburg : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
St. Petersburg : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Volgograd : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Slovakia
Banska Bysterica : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Bardejov : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Bratislava : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Bratislava : Investigative Site
Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure
Dunajska Streda : Diabetologia, poruchy latkovej premeny a vyzivy
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
View More »
Komarno : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Kosice : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Kosice : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Lucenec : Vseobecna nemocnica s poliklinikou Lucenec, n.o.
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Lucenec : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Modava nad Bodvou : Investigative site
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Nitra : Kardiocentrum NITRA s.r.o.
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
Nitra : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Presov : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
South Africa
Boksburg : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Cape Town : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Cape Town : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Durban : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Durban : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Durban : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Johannesburg : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Parow : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Pretoria : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Somerset West : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Somerset West : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Soweto : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Worcester : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Worcester : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Spain
Badalona : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Badalona : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Barcelona : Hospital Clinic de Barcelona
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
Barcelona : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Barcelona : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
El Palmar : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Granada : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Granada : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Madird : Hospital Doce de Octubre
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
Madrid : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Majadhonda : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Pamplona : Clinica Universitaria de Navarra
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
Sabadell : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Sabadell : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Santander : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Santiago de Compostela : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Valencia : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Valencia : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Sweden
Göteborg : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Göteborg : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Mölndal : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Malmö : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Malmö : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Mölndal : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Sundsvall : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Umeå : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Umeå : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Uppsala : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
United Kingdom
Bradford : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Bristol : University Hospitals Bristol, NHS Foundation Trust
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
Cottingham : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Coventry : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Glasgow : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
View More »
Harrow : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Kirkcaldy : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Leeds : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Leicester : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Liverpool : Liverpool Heart and Chest Hospital, NHS Foundation Trust
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
London : Imperial College Healthcare NHS Trust, St. Mary's Hospital
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
London : The Heart Hospital, University College London Hospitals, NHS Foundation Trust
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
London : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Romford : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
York : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
United States
Washington : Research Site
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
